logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Contrarian Investing
Filter

Contrarian Investing

Categories

Sectors

Locations

Exchange

Three Biotech Stocks Crushed the S&P 500 — Analysts Still Back Just One

From Weight Loss Drugs to Cancer Vaccines: A Contrarian Bet on Two Biotech Stocks

Jan 27, 2026

Life Science

Marvell and Micron: Can These AI Chip Stocks Still Be Chased after Triple-Digit Surges?

As NVIDIA Heats Up and Intel Cools, Is Qualcomm the Dark Horse of AI?

Jan 27, 2026

Technology

FDA Delays Lilly’s Weight-Loss Pill: Is the Stock Still a Buy for 2026?

FDA Delays Lilly’s Weight-Loss Pill: Is the Stock Still a Buy for 2026?

Jan 25, 2026

Life Science

Why Ackman Makes Contrarian Bet on Microsoft Amid Market Downtrend

Selling Intel, Buying Qualcomm: Why This Billionaire Is Betting on an ‘Atypical’ AI Chip Stock

Jan 25, 2026

Technology

Meta’s Cloud Pivot: Value Trap or Hidden Gold Mine?

Jefferies Bullish on Meta: Can the Cheapest ‘Magnificent Seven’ Stock Stage a Comeback?

Jan 22, 2026

Technology

As TSX Hits Record Highs, This Healthcare Tech Stock Sits in a "Value Gap"

As TSX Hits Record Highs, This Healthcare Tech Stock Sits in a “Value Gap”

Jan 20, 2026

Life Science, Technology

Boeing Shares Tumble 5.4% Despite China's First Major Jet Order in a Decade

Is Sub-CAD 20 Air Canada Stock Worth Buying in 2026?

Jan 19, 2026

Technology

Is Marvell Still a Buy After Its 10% Surge and Pullback?

From Pariah to Market Star: Imperial Metals Stages a 450% Turnaround

Jan 18, 2026

Base Metals

Two Beaten-Down Pharma Giants: Biotech’s Cyclical Turn Delivers Prime Dip-Buy Opportunities

Why Wall Street Still Bets on Microsoft Despite Months of Stock Slump

Jan 14, 2026

Technology

Senate Vote to Overturn Minnesota Mining Ban Exposes Deep Strategic Anxiety Over Critical Minerals

Trump Tantrum Sinks Financials, But Analysts Spy a Buying Opportunity

Jan 13, 2026

Financial Service

Rambus Shares Sink 21%, Overreaction or Opportunity?

Are These Canadian AI Stock Pullbacks a Buying Opportunity?

Jan 12, 2026

Technology

Three Consumer Giants Hit All-Time Highs as Tech Stocks Extend Retreat

Wall Street Cheers Lithium Giant Albemarle, Citing Start of New Upcycle

Jan 12, 2026

Energy Metals

Nvidia Unveils NemoClaw, an Open-Source Platform to Tame AI Agents for the Enterprise

SoundHound AI in 2026: High-Risk Bet or Hidden Gem in the Voice Revolution?

Jan 11, 2026

Technology

Oklo’s Nvidia Moment: A Real 10-Bagger or Just a Fission Fantasy?

NuScale Stock Is Down 50% While the Nuclear Sector Heats Up. Time to Buy?

Jan 11, 2026

Energy, Technology

Goldman’s Top Energy Picks: Are They Still Buys After Oil Prices Plunged?

Is Suncor Energy (SU) a Buy After Its Venezuela-Induced Dip?

Jan 5, 2026

Energy

Can UnitedHealth’s Jan. 27 Report Reverse Its Stock Slump?

Can UnitedHealth’s Jan. 27 Report Reverse Its Stock Slump?

Jan 4, 2026

Financial Service, Life Science

Has CNR Stock Bottomed Out? Assessing a Potential Right-Side Entry

Has CNR Stock Bottomed Out? Assessing a Potential Right-Side Entry

Jan 4, 2026

Energy

Is Pfizer’s 6.5% Dividend a Yield Trap? Q1 Results Put Speculation to Rest

Is Pfizer Stock, Now Under $25, a Buy?

Jan 1, 2026

Life Science

  • ‹‹ Previous
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada